Arabic Arabic English English French French German German
dark

Edoxaban may be effective treatment for atrial fibrillation after transcatheter aortic valve replacement

The anticoagulant edoxaban may be just as effective as warfarin for preventing heart attack or stroke in patients with atrial fibrillation (AF) who undergo transcatheter aortic valve replacement (TAVR), according to a large-scale international study led by Mount Sinai.   Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

If you witness a cardiac arrest, your actions could save a life

Next Post

Unwanted record: Russia’s COVID deaths hit new high in July

Related Posts
Total
0
Share